4d pharma (4d pharma) COGS-to-Revenue : 0.00 (As of Dec. 2021)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma COGS-to-Revenue?

4d pharma's Cost of Goods Sold for the six months ended in Dec. 2021 was $0.00 Mil. Its Revenue for the six months ended in Dec. 2021 was $0.39 Mil.

4d pharma's COGS to Revenue for the six months ended in Dec. 2021 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 4d pharma's Gross Margin % for the six months ended in Dec. 2021 was N/A%.

4d pharma COGS-to-Revenue Historical Data

The historical data trend for 4d pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma COGS-to-Revenue Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
COGS-to-Revenue	Get a 7-Day Free Trial											-	-	-	-	-

4d pharma COGS-to-Revenue Calculation

4d pharma's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.694
	=	0.00

4d pharma's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.386
	=	0.00

4d pharma (OTCPK:LBPWQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

4d pharma's Gross Margin % for the six months ended in Dec. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.386
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

4d pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4d pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.